Company intelligence / Profile preview
hVIVO
London, United Kingdomhvivo.com ↗
- Ownership
- Public · HVO
- Employees
- ~350
- Development stage
- Other
01
Overview
hVIVO leads the market in human challenge trials with over +75 studies completed. It provides end-to-end early clinical development services—including consultancy through Venn Life Sciences and early-phase clinical execution via CRS—with a unique portfolio of at least eleven validated human challenge models across major infectious disease indications. The company’s proprietary models are used by seven of the world’s ten largest biopharma companies to accelerate vaccine and therapeutic development.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Small moleculesvaccinesbiologics/antivirals
- Industry
- Contract Research Organization
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Joint venture with PepTcell Ltd. on Imutex Limited developing universal flu vaccine FLU-v and mosquito-borne disease vaccine AGS-vcontracts with seven of top ten global biopharma companies as clients
04
Financials
- Market cap
- $48.9M
- Total revenue
- $62.6M
- Enterprise value
- $50.1M
Beyond the preview
Go deeper on hVIVO.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hVIVO.